Rapid Dose Therapeutics Corp. filed its Annual on Jan 27, 2023 for the period ending Feb 28, 2022. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.245 CAD | -3.92% | +16.67% | +48.48% |
Mar. 25 | Rapid Dose Therapeutics Corp. announced that it expects to receive CAD 6 million in funding | CI |
Feb. 08 | Rapid Dose Therapeutics Corp. Appoints Angela O'Leary to the Board of Directors | CI |
1st Jan change | Capi. | |
---|---|---|
+48.48% | 22.5M | |
-8.89% | 187M |
- Stock Market
- Equities
- DOSE Stock
- News Rapid Dose Therapeutics Corp.
- Rapid Dose Therapeutics Corp. Auditor Raises 'Going Concern' Doubt